Intranasal antihistamine and corticosteroid to treat allergic rhinitis: A systematic review and meta-analysis
- PMID: 35716356
- DOI: 10.1111/all.15415
Intranasal antihistamine and corticosteroid to treat allergic rhinitis: A systematic review and meta-analysis
References
REFERENCES
-
- Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80 e73.
-
- Debbaneh PM, Bareiss AK, Wise SK, McCoul ED. Intranasal azelastine and fluticasone as combination therapy for allergic rhinitis: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161(3):412-418.
-
- Moher D, Shamseer L, Clarke M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.
-
- Gross GN, Berman G, Amar NJ, Caracta CF, Tantry SK. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Annals Allergy Asthma Immunol. 2019;122(6):630-638 e633.
-
- Meltzer EO, Wallace D, Dykewicz M, Shneyer L. Minimal clinically important difference (MCID) in allergic rhinitis: agency for healthcare research and quality or anchor-based thresholds? J Allergy Clin Immunol Pract. 2016;4(4):682-688. e686.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical